Latest filings (excl ownership)
15-12B
Securities registration termination
10 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
31 May 13
S-8 POS
Registration of securities for employees (post-effective amendment)
31 May 13
SC 13E3/A
Going private transaction (amended)
31 May 13
20-F/A
2012 FY
Annual report (foreign) (amended)
30 May 13
6-K
3SBio Inc. Announces Completion of Merger
30 May 13
25-NSE
Exchange delisting
29 May 13
6-K
3SBio Inc. Announces Shareholders’ Approval of the Amended Merger Agreement
24 May 13
6-K
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012
3 May 13
6-K
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
2 May 13
SC 13E3/A
Going private transaction (amended)
2 May 13
20-F
2012 FY
Annual report (foreign)
30 Apr 13
SC 13E3/A
Going private transaction (amended)
26 Apr 13
6-K
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
25 Apr 13
SC 13E3/A
Going private transaction (amended)
25 Apr 13
6-K
3SBio Inc. Enters Into Amendment to Merger Agreement For “Going Private” Transaction
24 Apr 13
6-K
3SBio Inc. Announces Receipt of Amended “Going Private” Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders
23 Apr 13
SC 13E3/A
Going private transaction (amended)
23 Apr 13
SC 13E3/A
Going private transaction (amended)
17 Apr 13
SC 13E3/A
Going private transaction (amended)
12 Apr 13
6-K
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
25 Mar 13
SC 13E3/A
Going private transaction (amended)
25 Mar 13
6-K
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results
22 Mar 13
SC 13E3/A
Going private transaction (amended)
20 Mar 13
UPLOAD
Letter from SEC
20 Mar 13
SC 13E3/A
Going private transaction (amended)
15 Mar 13
UPLOAD
Letter from SEC
12 Mar 13
SC 13E3
Going private transaction
4 Mar 13
6-K
3SBio Inc. Enters Into Merger Agreement For “Going Private” Transaction
8 Feb 13
6-K
Current report (foreign)
16 Nov 12
6-K
3SBIO Inc. Announces Results of 2012 Annual General Meeting
16 Oct 12
6-K
Current report (foreign)
2 Oct 12
6-K
Current report (foreign)
17 Sep 12
6-K
Current report (foreign)
12 Sep 12
6-K
Current report (foreign)
12 Sep 12
6-K
Current report (foreign)
21 Aug 12
6-K
3SBio Inc. Announces Changes to its Board of Directors
15 Aug 12
CT ORDER
Confidential treatment order
13 Jul 12
6-K
3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
5 Jul 12
6-K
Current report (foreign)
21 May 12
Latest ownership filings
SC 13D/A
Lou Jing
26 Apr 13
SC 13D/A
ORBIMED ADVISORS LLC
23 Apr 13
SC 13D/A
ORBIMED ADVISORS LLC
15 Apr 13
SC 13D/A
ORBIMED ADVISORS LLC
12 Apr 13
SC 13D/A
Lou Jing
11 Apr 13
SC 13D/A
ORBIMED ADVISORS LLC
11 Apr 13
SC 13D
ORBIMED ADVISORS LLC
8 Apr 13
SC 13D
Lou Dan
19 Feb 13
144
Notice of proposed sale of securities
19 Nov 10
144
Notice of proposed sale of securities
23 Feb 10
144
Notice of proposed sale of securities
14 Dec 09